November 2014

Spectranetics Overcomes Intellectual Property Challenges to Acquire Stellarex Platform

United States - Colorado

Faegre Baker Daniels represented the Spectranetics Corporation in its purchase of the Stellarex drug-coated balloon platform from Covidien LP. The transaction involved unique intellectual property challenges, in that Covidien had divested the Stellarex platform during its acquisition by Medtronic. FaegreBD's IP team was able to respond rapidly by performing intellectual property due diligence to ensure Spectranetics was able to acquire the desired technology. 

Services & Industries

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。